Literature DB >> 8779906

Permeability characteristics of erythrocyte membrane to okadaic acid and calyculin A.

A N Namboodiripad1, M L Jennings.   

Abstract

The rates of transport of the protein phosphatase inhibitors okadaic acid and calyculin A through rabbit erythrocyte membranes have been estimated by measuring protein phosphatase type 2A (PP2A) activity in lysates. High concentrations of okadaic acid (100 nM) cause rapid (t 1/2 approximately 10 min) inhibition of PP2A. However, the t 1/2 for okadaic acid influx is much longer because the concentration is much higher than the concentration inhibiting 50% of the maximal response (IC50). The estimated t 1/2 is over 1 h at 37 degrees C and over 4 h at 25 degrees C. The effect of low extracellular pH indicates that the undissociated acid is the permeant species. It takes hours to reverse the effect of okadaic acid, because the efflux must proceed through several half times before the concentration is below the IC50 for PP2A. The permeation of calyculin A in contrast to okadaic acid is too fast to measure at 25 degrees C. Our results indicate that okadaic acid entry into erythrocytes is slower than is generally believed; it is crucial to consider concentration, temperature, pH, and time of exposure to okadaic acid to interpret the effects of this agent on intact cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8779906     DOI: 10.1152/ajpcell.1996.270.2.C449

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Phosphorylation-independent association of CXCR2 with the protein phosphatase 2A core enzyme.

Authors:  G H Fan; W Yang; J Sai; A Richmond
Journal:  J Biol Chem       Date:  2001-02-26       Impact factor: 5.157

2.  Volume-sensitive K(+)/Cl(-) cotransport in rabbit erythrocytes. Analysis of the rate-limiting activation and inactivation events.

Authors:  M L Jennings
Journal:  J Gen Physiol       Date:  1999-12       Impact factor: 4.086

3.  CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.

Authors:  Richard V Parry; Jens M Chemnitz; Kenneth A Frauwirth; Anthony R Lanfranco; Inbal Braunstein; Sumire V Kobayashi; Peter S Linsley; Craig B Thompson; James L Riley
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

4.  S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.

Authors:  Usha Narayanan; Vijayalaxmi Nalavadi; Mika Nakamoto; George Thomas; Stephanie Ceman; Gary J Bassell; Stephen T Warren
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

5.  Activation of Na+/H+ exchange by protein phosphatase inhibitors in red blood cells of the frog Rana ridibunda.

Authors:  G P Gusev; T I Ivanova
Journal:  J Comp Physiol B       Date:  2003-05-20       Impact factor: 2.200

6.  Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome.

Authors:  Soong Ho Kim; Julie A Markham; Ivan Jeanne Weiler; William T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

7.  Protein phosphatase 2A plays an important role in migration of bone marrow stroma cells.

Authors:  Weiqian Chen; Shizhen Wang; Jun Xia; Zan Huang; Xin Tu; Zhenya Shen
Journal:  Mol Cell Biochem       Date:  2015-12-26       Impact factor: 3.396

8.  Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels.

Authors:  John D Imig; Christiana Dimitropoulou; D Sudarshan Reddy; Richard E White; John R Falck
Journal:  Microcirculation       Date:  2008-02       Impact factor: 2.628

9.  Calyculin A from Discodermia calyx is a dual action toxin that blocks calcium influx and inhibits protein Ser/Thr phosphatases.

Authors:  Maja Holy; David L Brautigan
Journal:  Toxins (Basel)       Date:  2012-10-22       Impact factor: 4.546

10.  Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.

Authors:  Lijing Li; Ludmila Krymskaya; Jianbin Wang; Jill Henley; Anitha Rao; Lan-Feng Cao; Chy-Anh Tran; Monica Torres-Coronado; Agnes Gardner; Nancy Gonzalez; Kenneth Kim; Pei-Qi Liu; Ursula Hofer; Evan Lopez; Philip D Gregory; Qing Liu; Michael C Holmes; Paula M Cannon; John A Zaia; David L DiGiusto
Journal:  Mol Ther       Date:  2013-04-16       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.